Citizens Financial Group Inc. RI purchased a new position in Humana Inc. (NYSE:HUM – Free Report) in the 2nd quarter, HoldingsChannel.com reports. The firm purchased 1,861 shares of the insurance provider’s stock, valued at approximately $739,000.
Other large investors also recently modified their holdings of the company. Mitsubishi UFJ Asset Management Co. Ltd. grew its position in Humana by 4.1% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 250,330 shares of the insurance provider’s stock valued at $66,207,000 after buying an additional 9,960 shares in the last quarter. Sustainable Insight Capital Management LLC increased its stake in Humana by 23.7% during the 4th quarter. Sustainable Insight Capital Management LLC now owns 24,757 shares of the insurance provider’s stock valued at $6,341,000 after buying an additional 4,740 shares during the period. Swedbank AB raised its position in shares of Humana by 6.2% during the 4th quarter. Swedbank AB now owns 111,803 shares of the insurance provider’s stock worth $28,636,000 after buying an additional 6,534 shares in the last quarter. North Dakota State Investment Board bought a new stake in shares of Humana during the 4th quarter worth about $1,517,000. Finally, Pzena Investment Management LLC lifted its stake in shares of Humana by 1.0% in the 4th quarter. Pzena Investment Management LLC now owns 4,072,208 shares of the insurance provider’s stock worth $1,043,015,000 after acquiring an additional 41,125 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.
Humana Price Performance
NYSE HUM opened at $377.18 on Thursday. The stock has a market capitalization of $45.29 billion, a P/E ratio of 35.68, a P/E/G ratio of 2.18 and a beta of 0.72. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $428.88. The business’s fifty day moving average is $383.16 and its two-hundred day moving average is $279.59. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74.
Analysts Set New Price Targets
HUM has been the subject of several recent analyst reports. William Blair began coverage on shares of Humana in a report on Wednesday, May 20th. They issued an “outperform” rating for the company. Barclays boosted their target price on Humana from $344.00 to $407.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Wolfe Research raised Humana from a “peer perform” rating to an “outperform” rating in a research note on Thursday, July 30th. Zacks Research lowered Humana from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 11th. Finally, Robert W. Baird set a $390.00 price target on Humana in a research report on Thursday, July 30th. Fourteen research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $395.22.
Get Our Latest Stock Report on HUM
Humana Profile
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Recommended Stories
- Five stocks we like better than Humana
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
